Related Experiment Video
Updated: Jul 14, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Sarcopenia as an important determinant for adverse outcomes in patients with pyogenic liver abscess
Li Liu1,2, Shaohua Liu1,2, Meng Hao3
1Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Background:
Low muscle mass/sarcopenia has been associated with poor prognosis in many diseases, but its clinical significance in pyogenic liver abscess (PLA) remains unclear. The purpose of this study is to investigate the relationship between muscle mass and prognosis of patients with PLA.
Methods:
A total of 154 adult patients with PLA hospitalized at Tongji Hospital (Wuhan, Hubei, China) between October 2011 and June 2021 were included in this retrospective analysis. Muscle-fat related indicators were measured by computed tomography (CT) images at the third lumbar vertebra (L3) level. The data of patients between the sarcopenia group and non-sarcopenia group were compared. Multivariate logistic regression and receiver operating characteristic (ROC) curve analyses were performed.
Results:
The skeletal muscle index (SMI) was independently associated with adverse outcomes (95% CI [0.649-0.954], P = 0.015) of PLA in multivariate logistic regression analysis. This conclusion held true in sex-specific subgroup analysis. ROC analysis indicated that SMI may predict adverse outcomes in both male (area under the ROC curve [AUC], 0.718; cut-off, 52.59; P < 0.001) and female (AUC, 0.714; cut-off, 38.39; P = 0.017) patient populations.
Conclusions:
Sarcopenia serves as an independent risk factor for poor prognosis in PLA and patients with sarcopenia may be more prone to adverse outcomes.
Insights
Sarcopenia, or low muscle mass, is an independent risk factor for poor prognosis in patients with pyogenic liver abscess (PLA). Patients with sarcopenia face a higher likelihood of adverse outcomes, highlighting its clinical significance.
Area of Science:
- Hepatology
- Geriatrics
- Radiology
Background:
- Low muscle mass (sarcopenia) is linked to poor prognosis in various diseases.
- The clinical significance of sarcopenia in pyogenic liver abscess (PLA) is not well-established.
- This study investigates the association between muscle mass and PLA patient prognosis.
Purpose of the Study:
- To determine if sarcopenia is associated with adverse outcomes in patients with pyogenic liver abscess.
- To evaluate the prognostic value of muscle mass indicators in PLA.
Main Methods:
- Retrospective analysis of 154 adult PLA patients.
- Muscle-fat indicators measured using CT scans at the L3 vertebral level.
- Comparison between sarcopenia and non-sarcopenia groups using multivariate logistic regression and ROC curve analysis.
Main Results:
- Skeletal muscle index (SMI) independently predicted adverse outcomes in PLA patients (95% CI [0.649-0.954], P=0.015).
- ROC analysis showed SMI could predict adverse outcomes in both male (AUC=0.718) and female (AUC=0.714) populations.
- Sex-specific cut-off values for SMI were identified for predicting adverse outcomes.
Conclusions:
- Sarcopenia is an independent risk factor for poor prognosis in pyogenic liver abscess.
- Patients with sarcopenia are at increased risk for adverse outcomes in PLA.
- SMI is a valuable prognostic indicator in PLA patients.
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Acute Pancreatitis II: Clinical Manifestations and Management
Nephrotic Syndrome I : Introduction

